Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Zalevsky Jonathan
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wilson Mark Andrew
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN HOWARD W
Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Nektar Therapeutics | 10-Q: Q2 2024 Earnings Report
Nektar Therapeutics | 8-K: Nektar Therapeutics Reports Second Quarter 2024 Financial Results
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CHESS ROBERT
Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Nektar Therapeutics | 8-K: Current report
Nektar Therapeutics | EFFECT: Others
Nektar Therapeutics | 424B3: Prospectus
Nektar Therapeutics | CORRESP: CORRESP
Nektar Therapeutics | UPLOAD: Others
Nektar Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN HOWARD W
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Zalevsky Jonathan
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wilson Mark Andrew
Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data
No Data